Boston, MA—Findings in a new study published in Osteoporosis International show that calcium supplementation (more than 1,000 mg/day) did not increase a woman’s the risk of cardiovascular disease(CVD).
Washington, D.C.—Television personality Mehmet Oz, M.D., testified in Capitol Hill on June 17, in front of a senate panel investigating how to protect consumers from false and deceptive advertising of weight-loss products.
Daniel Fabricant, Ph.D., addressed the Ingredient Marketplace crowd in early June with a presentation entitled, “There and Back Again.” Reflecting upon his time as the director of the U.S. Food and Drug Administration’s (FDA) division of dietary supplements, Fabricant, now executive director and CEO of the Natural Products Association (NPA), offered insight into FDA’s current thinking on dietary supplements and what could be on the agency’s radar for the future.
Washington, D.C.— Sen. Martin Heinrich (D-NM) has cosigned the Designer Anabolic Steroid Act (DASCA), legislation designed to give the Drug Enforcement Administration (DEA) authority to place designer anabolic steroids in the Drug Enforcement Schedules quicker.
Washington, D.C.—The Natural Products Association (NPA) recently installed Daniel Fabricant, Ph.D., as its new executive director and CEO. He returns to NPA after serving as the director of the Division of Dietary Supplement Programs at the U.S. Food and Drug Administration (FDA) for three years.
On the beautiful afternoon of April 8 in Washington, D.C., the Natural Products Association (NPA) held its 17th annual Natural Products Day. The event is designed to allow retailers and other natural products industry stakeholders to lobby their elected representatives on behalf of the industry’s interests.
Washington, D.C.—The Council for Responsible Nutrition (CRN) issued a statement regarding a study that found a diet rich in polyunsaturated fats and low in saturated fats does not provide heart health benefits.
Austin, TX—The American Botanical Council’s (ABC) 2013 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award has been presented to Wakunaga Pharmaceutical Company, LLC (Osaka, Japan). Wakunaga is the maker of Kyolic Aged Garlic Extract.